Single-cell sequencing uncovers clonal dynamics profiles and therapeutic resistance biomarkers in relapsed and refractory peripheral T-cell lymphoma - Top-Institutions - MDSpire

Single-cell sequencing uncovers clonal dynamics profiles and therapeutic resistance biomarkers in relapsed and refractory peripheral T-cell lymphoma

  • By

  • Ning Zhang

  • Jingwei Yu

  • Hengqi Liu

  • Zechao Hu

  • Shen Meng

  • Cong Sun

  • Yaxiao Lu

  • Xia Liu

  • Zheng Song

  • Lanfang Li

  • Lihua Qiu

  • Zhengzi Qian

  • Bin Meng

  • Wenchen Gong

  • Shiyong Zhou

  • Xianhuo Wang

  • Huilai Zhang

  • July 10, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Hematology
    • Oncology

  • #2

    Tianjin Medical University Cancer Institute and Hospital
    Tianjin Medical University Cancer Institute and Hospital

    Tianjin, Tianjin

    Key Differentiators

    • Hematology
    • Oncology

  • #3

    Peking Union Medical College Hospital
    Peking Union Medical College Hospital

    Beijing, Beijing

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

Single-cell sequencing uncovers clonal dynamics profiles and therapeutic resistance biomarkers in relapsed and refractory peripheral T-cell lymphoma

  • by Ning Zhang, Jingwei Yu, Hengqi Liu, Zechao Hu, Shen Meng, Cong Sun, Yaxiao Lu, Xia Liu, Zheng Song, Lanfang Li, Lihua Qiu, Zhengzi Qian, Bin Meng, Wenchen Gong, Shiyong Zhou, Xianhuo Wang, Huilai Zhang

  • July 10, 2026

Related Content

The emerging roles of eosinophils in immune regulation in health and disease

Targeted lipid metabolism screening uncovers regulatory effects on the STING immune response in mevalonate, eicosanoid and fatty acid pathways

Beyond the dose-volume histogram: a critical appraisal of normal tissue complication probability modelling for osteoradionecrosis of the jaw and a strategic framework for clinical translation